Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
| Generic Name | Brand Name |
|---|---|
| hepatitis A inactivated and hepatitis B recombinant vaccine | Twinrix |
Twinrix is a vaccine that provides active immunity against both the hepatitis A and hepatitis B viruses. It is given in a series of 3 injections on the same schedule as the hepatitis B vaccine: an initial dose followed by doses at 1 month and 6 months.
The vaccine can prevent infection with one series of injections rather than two series. The U.S. Food and Drug Administration (FDA) has approved its use only for people age 18 or older who are at risk of infection with the hepatitis A virus (HAV) and the hepatitis B virus (HBV). These include people who:
In clinical trials, 1 month after the last dose, 100% of people were immune to hepatitis A, while 99.7% were immune to hepatitis B.1 But in practice, immunity may not approach these levels. Hepatitis B vaccine usually does not provide immunity for more than 95% to 97% of people.
Immunity to the hepatitis B virus is thought to be lifelong. The hepatitis A vaccine is effective for at least 10 years.1
In trials of the vaccine, no serious side effects occurred. The most common side effects were those that occur with the individual hepatitis A and B vaccines, such as:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Twinrix should not be given to people who are allergic to the contents of the vaccine.
The vaccine has not been tested in pregnant or breast-feeding women, so its safety for these women and their babies is unknown.
To be most effective before travel, two doses need to be given before departure. If only one dose can be given, consider having the individual hepatitis A vaccine instead of one shot of combination vaccine. It may provide better protection against hepatitis A.1
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- Twinrix: A combination hepatitis A and B vaccine (2001). Medical Letter on Drugs and Therapeutics, 43(1110): 67–68.
- Chaves SS (2009). Hepatitis B section of Pre-travel consultation: Travel-related vaccine-preventable diseases. In GW Brunette et al., eds., Travelers’ Health–Yellow Book. Atlanta: Centers for Disease Control and Prevention. Also available online: http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/hepatitis-b.aspx.
Last Revised: August 30, 2010
Author: Healthwise Staff
Medical Review: Kathleen Romito, MD - Family Medicine & Adam Husney, MD, MD - Family Medicine
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Steps @Sanfordhealth takes to plan for disasters http://t.co/Iy65PMivGG